PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
August 25, 2025World Journal of Biology Pharmacy and Health Sciences

Advances in pharmacotherapy of NASH

View Full Paper
Ask AI
Bookmark
Share

Authors

DVDivya Ratan VermaSSS. Suganthi

Discussion

Loading...

Member takes

Overview

Recent advances demonstrate new therapies for nash, indicating improved management of liver conditions.

Key Points

  • NASH therapies have shown promise, targeting pathways like inflammation and fibrosis for better outcomes.
  • Key developments include FXR agonists and GLP-1 receptor agonists, with several drugs under investigation.
  • Observational analysis highlights non-invasive biomarkers for monitoring nash progression and treatment response.
  • Ongoing challenges persist in safety, patient variability, and regulatory approval processes for these therapies.

Cite This Study

Verma et al. (2025) studied this question.

synapsesocial.com/papers/68af5d75ad7bf08b1eae144bhttps://doi.org/10.30574/wjbphs.2025.23.2.0767
View Full Paper
Ask AI
Bookmark
Share